Results 231 to 239 of about 198,185 (239)

Chimaeric anti-CD4 monoclonal antibody cross-linked by monocyte Fcγ receptor mediates apoptosis of human CD4 lymphocytes

European Journal of Immunology, 1993
Ernest Choy, James Adjaye, Gabrielle H Kingsley   +2 more
exaly  

Improvement of reduced serum cartilage oligomeric matrix protein levels in systemic juvenile idiopathic arthritis patients treated with the anti-interleukin-6 receptor monoclonal antibody tocilizumab

Modern Rheumatology, 2009
Shoko Nakajima, Tomoyuki Imagawa, Masaaki Mori   +2 more
exaly  

Anti-transferrin receptor monoclonal antibody and toxin–antibody conjugates affect growth of human tumour cells

Nature, 1981
I S Trowbridge, Trowbridge Ian S
exaly  

An anti-acetylcholine receptor monoclonal antibody cross-reacts with phosvitin

FEBS Letters, 1983
Adrienne S Gordon, Miriam C Souroujon, Ayala Sharp   +2 more
exaly  

Immunoprecipitation of an Affinity-Alkylated Fragment of the Muscarinic Acetylcholine Receptor with an Anti-Ligand Monoclonal Antibody

Journal of Neurochemistry, 1987
Neil M Nathanson
exaly  

The Fab Fragment of a Humanized Anti-Toll Like Receptor 4 (TLR4) Monoclonal Antibody Reduces the Lipopolysaccharide Response via TLR4 in Mouse Macrophage

International Journal of Molecular Sciences, 2015
Xuhui Zhu, Zhenqing Feng, Zhu Xuhui
exaly  

Humanized anti-interleukin-6 receptor monoclonal antibody induced apoptosis of fresh and cloned human myeloma cells in vitro

Leukemia Research, 2003
Toshiya Sumikuma, Hideo Gotō, Tohru Inaba   +2 more
exaly  

A double-blind placebo-controlled study of satralizumab (SA237), a recycling anti-IL-6 receptor monoclonal antibody, as monotherapy for patients with neuromyelitis optica spectrum disorder (NMOSD)

2018
openaire   +1 more source

Anti‐IL21 receptor monoclonal antibody (ATR‐107): Safety, pharmacokinetics, and pharmacodynamic evaluation in healthy volunteers: A phase I, first‐in‐human study

Journal of Clinical Pharmacology, 2014
Gail M Comer, Lori Stockert, Jean S Beebe   +2 more
exaly